secwatch.observer — SEC 8-K summary
======================================

Issuer:     CITIUS ONCOLOGY, INC. (CTOR)
CIK:        0001851484
Form:       8-K
Filed at:   2024-06-18T23:59:59+00:00
Accession:  0001493152-24-024236
Event type: debt
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

TenX Keane extends SPAC deadline to July 18 with $66,667 Citius Pharma deposit
------------------------------------------------------------------------------

- Citius Pharma deposited $66,667 into TenX Keane trust account to extend business combination timeline from June 18 to July 18, 2024.
- TenX issued $66,667 unsecured promissory note to Citius Pharma, no interest, repayable upon business combination close.
- This is the third of up to seven allowed monthly extensions; prior deposits on April 26 and May 17, 2024.
- Extension supports pending Merger Agreement to acquire Citius Oncology; repayment condition tied to trust account balance ≥$2M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1851484/000149315224024236/0001493152-24-024236-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1851484/000149315224024236/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-024236

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer